Trials / Conditions / Attention Deficit Disorders With Hyperactivity

Attention Deficit Disorders With Hyperactivity

7 registered clinical trials studyying Attention Deficit Disorders With Hyperactivity.

Status	Trial	Sponsor	Phase
Terminated	Pharmacogenomics for Improving Pediatric ADHD Treatment NCT03730870	Clinical and Translational Genome Research Institute, Inc.	N/A
Unknown	Event-related Potentials in Management of Children With Attention-deficit/Hyperactivity Disorder NCT01130467	Far Eastern Memorial Hospital	—
Completed	A Study to Evaluate Pharmacokinetics, Safety and Tolerability After a Single Dose Administration of of JNJ-310 NCT00890240	Johnson & Johnson Pharmaceutical Research & Development, L.L.C.	Phase 1
Completed	A Study to Evaluate Pharmacokinetics, Safety and Tolerability After a Single Dose Administration of JNJ-310010 NCT00890292	Johnson & Johnson Pharmaceutical Research & Development, L.L.C.	Phase 1
Unknown	Adverse Effect of Prolonged Methylphenidate Treatment on Cardiac Functions NCT00372359	Ornit Cohen	—
Completed	An Open-label Study of NRP104 in Adults With Attention Deficit Hyperactivity Disorder (ADHD) NCT00337285	New River Pharmaceuticals	Phase 3
Completed	Study to Assess the Safety and Efficacy of NRP104 in Adults With Attention-Deficit Hyperactivity Disorder (ADH NCT00334880	New River Pharmaceuticals	Phase 3